US Patent Issued to Turning Point Therapeutics on Oct. 14 for "Diaryl macrocycles as modulators of protein kinases" (New Jersey Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. RE50,634, issued on Oct. 14, was assigned to Turning Point Therapeutics Inc. (Princeton, N.J.).

"Diaryl macrocycles as modulators of protein kinases" was invented by Jingrong Jean Cui (Princeton, N.J.), Yishan Li (Princeton, N.J.), Evan W. Rogers (Princeton, N.J.) and Dayong Zhai (Princeton, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to certain diaryl macrocyclic compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating cancer, pain, neurological diseases, autoimmune diseases, and inflammation."

The patent was filed on Dec. 29, 2022, under Application No. 18/147...